Skip to main content

Catalyst Calendar

Scope

Wed, Aug 5, 2026

1 updates
RXRX
6:30 AM

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated targets for drug discovery REC-4881 (MEK1/2 inhibitor): Additional Phase 2 data in Familial

Presentation / Abstract • Phase 2CGA-IGC presentation Sun, Nov 1, 2026recursion.com

Tue, Aug 4, 2026

1 updates
RXRX
8:00 AM

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in the following upcoming investor conferences: Bank of America 2026 SMID Cap Executive Insights

recursion.com

Fri, Jul 31, 2026

1 updates

Wed, Jul 29, 2026

1 updates

Tue, Jun 2, 2026

1 updates
RXRX
8:00 AM

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in an upcoming investor conference: Goldman Sachs 47th Annual Global Healthcare Conference —

recursion.com

Fri, May 29, 2026

1 updates